Epinephrine

• Epinephrine versus Isoprenaline During Out-of-Hospital Cardiac Arrest with Non-Shockable Rhytm (EPISO) Not authorised
  2024-516074-29-00 Phase III 1 country Odense University Hospital
• Adductor canal and IPACK (infiltration between the popliteal artery and the capsule of the knee) blocks versus genicular nerves block for to… Pending
  2025-523071-34-00 Phase IV 1 country Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques Augus…
• Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria Recruiting
  2025-522878-36-00 Phase III 16 countries Celldex Therapeutics Inc.
• Phase 3 Study of Barzolvolimab in Participants with Cold Induced Urticaria and Symptomatic Dermographism Recruiting
  2025-522583-32-00 Phase III 4 countries Celldex Therapeutics Inc.
• method VALIDation and evaluation of non-radioactive methods to measure Glomerular Filtration Rate Recruiting
  2023-509156-34-02 Phase IV 1 country Universitair Medisch Centrum Groningen
• Comparison of Two Pain and Bleeding Control Methods in Back Surgery: A Study on Periarticular Vasoconstrictor Infiltration (PIV) vs. Erector… Recruiting
  2025-521572-56-00 Phase III 1 country Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau
• Umbilical vein catheterization through Wharton’s jelly in the delivery room : CaDOm multicenter clinical trial. Recruiting
  2024-515249-41-00 Phase II/III 1 country Hopital NOVO
• Comparison between Ropivacain and Lidocain for post-tonsillectomy pain Recruiting
  2025-520820-44-00 Phase IV 1 country Tauernkliniken GmbH A.ö. Tauernklinikum - Standort Zell am See
• VAsopressin and STeroids in addition to Adrenaline in cardiac arrest - a randomized clinical trial. VAST-A Ended
  2025-521283-35-00 Phase III 1 country Tiohundra AB
• A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Ended
  2024-513210-36-00 Phase III 10 countries Celldex Therapeutics Inc.
• A Phase 3 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria (EMBARQ – CSU1) Ended
  2024-513208-32-00 Phase III 11 countries Celldex Therapeutics Inc.
• METIMMOX-2: Oxaliplatin Chemotherapy and Immunotherapy to Patients with the Common pMMR/MSS Type of Large Bowel Cancer Spread to Other Organ… Ended
  2022-500027-76-00 Phase II 1 country Akershus University Hospital
• Efficacy of early intravenous high-dose vitamin C in post-cardiac arrest shock: a multicenter, randomized controled to standard treatment, o… Halted
  2022-500717-64-00 Phase II 1 country Centre Hospitalier Bethune Beuvry
• A Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Adults with Active Eosinophilic Esophagitis (The… Ended
  2024-512767-30-00 Phase II 4 countries Celldex Therapeutics Inc.
• Long-term extension study of ligelizumab in food allergy Ended
  2022-502366-25-00 Phase III 5 countries Novartis Pharma AG
• Safety and Preliminary Efficacy Assessment of AZD7789 in Patients With Relapsed or Refractory Classical Hodgkin Lymphoma Ended
  2022-502773-41-00 Phase I/II 4 countries AstraZeneca AB
• VAsopressin and STeroids in addition to Adrenaline in cardiac arrest - a randomized clinical trial. VAST-A Expired
  2022-500137-89-00 Phase III 1 country Tiohundra AB

Showing 1–17 of 17 trials